Bleeding Control Kits Market Size, Share, and Growth Forecast 2026 - 2033

Bleeding Control Kits Market by Product Type (Medical Gloves, Tourniquet, Trauma Shears, Compressed Gauze, Compression Bandage), End-user (Clinics, Industries & Corporate Offices, Hospitals, Sports Academies, Aviation, Automobiles, Defense, Academic Institutes, Healthcare Facilities, Emergency Medical Services), and Regional Analysis, 2026 - 2033

ID: PMRREP33986
Calendar

July 2026

177 Pages

Author : Abhijeet Surwase

Bleeding Control Kits Market Size and Trend Analysis

The global bleeding control kits market size is expected to be valued at US$ 6.3 billion in 2026 and projected to reach US$ 8.0 billion by 2033, growing at a CAGR of 3.5% between 2026 and 2033.

The global market is witnessing steady growth due to rising awareness regarding emergency hemorrhage management across civilian, military, and healthcare settings. Increasing incidence of traumatic injuries, road accidents, workplace emergencies, and mass casualty events has accelerated demand for rapid bleeding control solutions globally.

Governments and healthcare organizations are actively promoting public-access bleeding control initiatives, particularly through programs such as the U.S. Department of Homeland Security’s Stop the Bleed campaign. In addition, expanding procurement across defense agencies, hospitals, schools, and corporate workplaces, along with stricter workplace first-aid compliance regulations, continues to support market expansion. Technological advancements in tourniquets, hemostatic dressings, and trauma care products are further strengthening adoption of bleeding control kits across both developed and emerging markets.

Key Industry Highlights:

  • Leading Region: North America dominated the global bleeding control kits market with ~41% revenue share in 2026, supported by strong U.S. DoD/FEMA procurement, Stop the Bleed initiatives, and OSHA workplace safety compliance requirements.
  • Fastest Growing Region: Asia Pacific emerged as the fastest-growing regional market through 2033 due to rising military modernization programs, expanding emergency preparedness initiatives, and increasing workplace safety awareness across China, India, and Southeast Asia.
  • Leading Product Segment: Tourniquets held the leading product segment with ~34% share in 2026, driven by widespread adoption across military, EMS, trauma care, and public-access bleeding control programs globally.
  • Fastest Growing Segment: Medical gloves are projected to witness the fastest growth through 2033 owing to heightened infection-control awareness, post-pandemic emergency response protocols, and regulatory emphasis on universal safety precautions.
  • Key Opportunity: Corporate and industrial workplaces represent the largest untapped opportunity, as low penetration of bleeding control kits combined with increasing ESG-driven employee safety investments accelerates institutional procurement demand.

bleeding-control-kits-market-size-2026-2033

See exactly what you're buying — Before you spend a dollar.

Get a free sample copy of our market report: data, tables, charts, research depth, analyst insights, and relevance of our research - all in hand before you commit.

Market Dynamics

Drivers - Government Bleeding Control Awareness Programs Driving Global Civilian Emergency Preparedness Kit Adoption

Government-led public bleeding control awareness programs are significantly accelerating global demand for bleeding control kits. The U.S. Department of Defense-backed STOP THE BLEED® initiative, launched in 2015 with support from the American College of Surgeons (ACS), surpassed 5 million trained individuals globally in 2025 across more than 141 countries. The program promotes immediate civilian intervention during trauma emergencies and strongly encourages accessibility of standardized bleeding control kits in schools, airports, workplaces, sports venues, and other public locations.

Rising concerns regarding mass casualty incidents, road accidents, workplace injuries, and disaster preparedness are further strengthening institutional and civilian adoption of hemorrhage control products. In parallel, bleeding control education initiatives led by organizations such as the British Red Cross and St John Ambulance continue expanding across Europe. Additionally, Hartford Consensus recommendations supporting public access to tourniquets, hemostatic gauze, and trauma kits have increased procurement among hospitals, law enforcement agencies, schools, and corporate workplaces, creating sustained long-term market demand globally.

Restraints - Limited Awareness and Training Penetration in Developing Economies

Despite increasing global focus on civilian hemorrhage control, awareness and adoption of bleeding control kits remain heavily concentrated in developed North American and European markets. Many low- and middle-income countries (LMICs) lack structured public bleeding control education programs, resulting in limited understanding of emergency hemorrhage management among civilians, workplaces, and educational institutions. In addition, inadequate emergency response infrastructure and low institutional funding continue to restrict procurement of standardized bleeding control kits across hospitals, schools, transportation hubs, and public-access environments.

According to the World Health Organization (WHO), traumatic injuries account for ~4.4 million deaths annually worldwide, with a significant burden occurring in LMICs. However, systematic bleeding control preparedness initiatives remain underdeveloped across large parts of Asia, Africa, and Latin America. Limited healthcare budgets, lack of regulatory mandates, insufficient first-aid training penetration, and lower public safety investment continue to constrain market expansion in these high-population regions. As a result, manufacturers face challenges in generating large-scale civilian demand and establishing broad commercial distribution networks in emerging economies.

Opportunities - Medical Gloves Segment Driving Growth Through Infection Control Integration

The medical gloves segment represents one of the fastest-growing opportunities within the global bleeding control kits market, supported by rising emphasis on infection prevention during emergency response procedures. The COVID-19 pandemic significantly increased public and institutional awareness regarding pathogen transmission risks during first-aid interventions, making glove usage a standard safety practice among trained bystanders, emergency responders, and healthcare professionals. This shift has accelerated demand for bleeding control kits containing integrated personal protective equipment components.

Regulatory agencies including the U.S. FDA and European health authorities have strengthened infection-control guidance across emergency preparedness and trauma response protocols. Consequently, manufacturers are increasingly incorporating high-quality nitrile gloves alongside tourniquets, gauze, compression bandages, and trauma accessories within standardized bleeding control kits. Demand is particularly strong across schools, workplaces, airports, military facilities, and public venues seeking comprehensive emergency preparedness solutions. In addition, rising preference for disposable and latex-free protective products is enabling premium product positioning, creating significant revenue growth opportunities for manufacturers focused on advanced infection-safe bleeding control kit solutions globally.

Category-wise Analysis

Product Type Insights

The tourniquet segment is likely to command a dominant position within the bleeding control kits market by product type, accounting for ~34% of global share in 2026. Tourniquets are universally recognized as the single most effective intervention for extremity hemorrhage control, with the American College of Surgeons documenting that junctional and extremity bleeding accounts for the majority of preventable trauma deaths.

Military experience, particularly from U.S. conflicts in Iraq and Afghanistan, validated the life-saving effectiveness of the Combat Application Tourniquet (C-A-T) and similar devices, directly driving their adoption into civilian and first-responder protocols. The CoTCCC and Hartford Consensus guidelines both mandate tourniquet inclusion in all bleeding control kits, structurally anchoring demand. Leading manufacturers including North American Rescue, LLC and C-A-T Resources, LLC benefit from deep military procurement relationships that sustain high-volume production and competitive unit economics.

End-user Insights

The defense segment is likely to lead the end-user category for bleeding control kits, representing ~28% of global revenue share in 2026. Defense procurement is structurally differentiated by its large-scale, contract-driven purchasing model, with national defense establishments procuring bleeding control kit components, particularly Individual First Aid Kits (IFAKs) in bulk for operational deployment, training exercises, and stockpiling.

The U.S. Department of Defense alone allocates hundreds of millions of dollars annually to combat medical supply procurement, with bleeding control components constituting a core portion of soldier-level medical load-outs. NATO standardization agreements (STANAGs) for combat casualty care further harmonize bleeding control kit specifications across member-state militaries, creating a large, specification-aligned multinational procurement base. International defense modernization programs in India, South Korea, and Australia are additionally expanding global defense-sector demand.

bleeding-control-kits-market-outlook-by-product-type-2026–2033

Not every business fits the same mold. Your research shouldn't either.

Connect with the team for a customization and get a one-of-a-kind report scoped to your niche — The insights your competitors won't have access to.

Regional Insights

North America Bleeding Control Kits Market Trends and Insights

North America dominates the global bleeding control kits market with ~41% revenue share in 2026, supported by strong procurement from U.S. defense and emergency response agencies. Widespread adoption of the Stop the Bleed initiative, increasing public hemorrhage control awareness, and OSHA workplace safety compliance standards continue driving institutional and civilian demand. Growing state-level legislation mandating bleeding control kits across schools, airports, workplaces, and public buildings is further accelerating market expansion.

In addition, robust commercial distribution networks, advanced EMS infrastructure, and high military spending continue strengthening regional leadership across the bleeding control preparedness and trauma response market.

U.S. Bleeding Control Kits Market Size

The U.S. accounts for ~85% of North American bleeding control kit revenues, driven by large-scale procurement from the Department of Defense (DoD), FEMA, EMS agencies, and healthcare institutions. The country has the highest global penetration of Stop the Bleed-trained civilians, supported by extensive public awareness campaigns and emergency preparedness programs. Increasing state mandates requiring bleeding control kits in schools, workplaces, and public venues continue boosting civilian demand. In addition, strong distribution infrastructure, rising tactical medicine adoption, and growing investments in trauma preparedness across corporate and industrial sectors support sustained market growth in the U.S.

Europe Bleeding Control Kits Market Trends and Insights

Europe represents the second-largest regional market for bleeding control kits, supported by growing public hemorrhage control awareness and increasing military procurement among NATO member states. Organizations including the British Red Cross and German Red Cross are expanding civilian emergency response education across schools, workplaces, and public-access environments. Regulatory harmonization under the EU Medical Device Regulation (MDR 2017/745) is improving product quality standards and procurement consistency across regional markets.

Increasing focus on workplace safety, disaster preparedness, and emergency trauma response capabilities continues driving adoption of bleeding control kits across healthcare institutions, transportation hubs, and public infrastructure throughout Europe.

Germany Bleeding Control Kits Market Size

Germany holds the largest share within the European bleeding control kits market, accounting for ~22% of regional revenues. Market growth is supported by procurement from the Bundeswehr (German Armed Forces), rising industrial workplace safety requirements, and strong occupational health regulations under DGUV standards. Increasing adoption of hemorrhage control preparedness across manufacturing facilities, transportation sectors, and emergency response agencies continues supporting demand.

In addition, Germany’s advanced healthcare infrastructure and strong emphasis on trauma care preparedness are accelerating adoption of tourniquets, hemostatic dressings, and public-access bleeding control kits across institutional and civilian settings.

UK Bleeding Control Kits Market Size

The UK accounts for ~18% of European bleeding control kits revenues, driven by NHS emergency preparedness initiatives and increasing procurement by Hazardous Area Response Teams (HART). Public awareness regarding hemorrhage control significantly increased following the Manchester Arena and London Bridge attacks, encouraging broader adoption of bleeding control resources across schools, transportation hubs, and public venues. Organizations such as the British Red Cross and St John Ambulance continue expanding civilian hemorrhage control training programs nationwide.

In addition, growing workplace safety compliance and government focus on public emergency preparedness are supporting long-term institutional and civilian market growth across the UK.

Asia Pacific Bleeding Control Kits Market Trends and Insights

Asia Pacific is projected to be the fastest-growing regional market for bleeding control kits through 2033, driven by rising defense spending, expanding industrial workplace safety investments, and increasing emergency preparedness initiatives. Countries including China, India, Japan, and South Korea are strengthening trauma response infrastructure and military modernization programs, supporting institutional procurement growth. Rapid urbanization, growing road accident incidence, and increasing public awareness regarding emergency hemorrhage management are further accelerating civilian adoption.

In addition, domestic manufacturers across China and Southeast Asia are expanding production capabilities and improving price competitiveness, contributing to broader market penetration across developing economies in the region.

India Bleeding Control Kits Market Size

India represents the fastest-growing national market within Asia Pacific, accounting for ~15% of regional revenues. Growth is driven by procurement from the Indian Army, Central Armed Police Forces (CAPF), and expanding hospital emergency preparedness initiatives. Increasing awareness campaigns led by the National Disaster Management Authority (NDMA) are promoting community-level emergency response and hemorrhage control preparedness. Rising industrial safety compliance, expanding healthcare infrastructure, and increasing workplace first-aid investments are also contributing to market growth.

In addition, growing urbanization and rising incidence of road traffic injuries continue supporting demand for bleeding control products across civilian and institutional settings.

Japan Bleeding Control Kits Market Size

Japan accounts for ~18% of Asia Pacific bleeding control kit revenues, supported by stringent institutional quality standards and procurement from the Japan Self-Defense Forces (JSDF). The country’s disaster-prone geography and emphasis on emergency preparedness continue driving demand for trauma response products across healthcare, transportation, and industrial sectors. Workplace safety investments under Ministry of Health, Labour and Welfare (MHLW) guidelines are encouraging broader adoption of hemorrhage control kits and emergency medical supplies.

Additionally, increasing focus on public disaster readiness, aging infrastructure safety, and advanced emergency response capabilities is supporting stable long-term market growth in Japan.

China Bleeding Control Kits Market Size

China represents one of the largest and fastest-expanding bleeding control kits markets in Asia Pacific, supported by modernization programs within the People’s Liberation Army (PLA) and rising industrial safety investments. Growing government focus on emergency preparedness, workplace safety compliance, and disaster response infrastructure is accelerating institutional procurement of trauma care products. Domestic manufacturers are increasingly competing through cost-effective bleeding control solutions, improving accessibility across hospitals, industrial facilities, and emergency response organizations.

In addition, rapid urbanization, rising accident incidence, and expanding healthcare infrastructure are creating strong long-term demand for bleeding control kits across both civilian and military applications in China.

bleeding-control-kits-market-outlook-by-region-2026-2033

Competitive Landscape

The global bleeding control kits market is moderately fragmented, with North American Rescue, LLC, Teleflex Incorporated, and SAM Medical Products collectively representing leading market positions through their established defense and emergency services procurement relationships. Key differentiators include military-specification compliance certifications (MIL-SPEC), FDA clearances for individual device components, and training program integration capabilities. Competitive strategies increasingly encompass direct-to-consumer digital commerce channel development, subscription-based kit replenishment models, and co-branded corporate safety program partnerships.

Emerging players are leveraging advanced hemostatic gauze formulations and compact packaging innovations to differentiate in the civilian and corporate end-user segments against established tactical medical supply incumbents.

Key Developments

  • In July 2025, the American College of Surgeons announced that its STOP THE BLEED® program surpassed 5 million trained individuals across 141 countries, significantly expanding global civilian hemorrhage control preparedness and emergency response awareness.
  • In January 2025, TyTek Medical expanded its trauma care portfolio by manufacturing emergency medical supplies including bandages, compressed gauze, chest decompression needles, portable suction units, and shears.
  • In March 2024, New Jersey’s Office of Homeland Security distributed bleeding control kits to houses of worship statewide to improve emergency preparedness for active shooter incidents before first responders arrive.
  • In May 2023, the American College of Surgeons expanded its STOP THE BLEED initiative to educate the public on lifesaving hemorrhage control techniques and emergency bleeding response preparedness.

Companies Covered in Bleeding Control Kits Market

  • North American Rescue, LLC
  • Teleflex Incorporated
  • SAM Medical Products
  • Tactical Medical Solutions, Inc.
  • RevMedx Inc.
  • PerSys Medical
  • Dynarex Corporation
  • Medline Industries, LP
  • Cardinal Health, Inc.
  • TyTek Medical
  • H&H Medical Corporation
  • C-A-T Resources, LLC
  • Others
Frequently Asked Questions

The global bleeding control kits market is estimated to be valued at US$ 6.3 billion in 2026.

Primary demand drivers include Stop the Bleed programs, OSHA workplace safety compliance, rising trauma cases, and increasing military procurement of hemorrhage control products globally.

North America leads the market due to strong government initiatives, high civilian training penetration, advanced EMS infrastructure, and substantial institutional procurement across the U.S.

The key growth opportunity lies in increasing adoption across workplaces, schools, and public buildings supported by safety regulations and growing corporate emergency preparedness investments.

Key players include North American Rescue, LLC, Teleflex Incorporated, SAM Medical Products, RevMedx Inc., and Cardinal Health, Inc., among others.

UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -